医学
麻醉药
对乙酰氨基酚
药丸
麻醉
羟考酮
外科
鼻中隔成形术
类阿片
鼻子
内科学
药理学
受体
作者
Sifon Ndon,Todd Spock,Sina J. Torabi,R. Peter Manes
标识
DOI:10.1177/0194599820915472
摘要
To evaluate postoperative opiate use and patients' opinions regarding pain management after endoscopic sinus surgery (ESS).Case series with planned data collection.Tertiary referral medical center.We prospectively evaluated postoperative opiate utilization in adults undergoing ESS over a 2-year period at an academic medical facility. Exclusion criteria included use of nasal packing, intracranial or orbital procedures, tumor surgery, and any use of endoscopic drills. All patients underwent bilateral maxillary antrostomy, total ethmoidectomy, sphenoidotomy, and frontal sinusotomy with or without septoplasty. Patients were discharged with 30 oxycodone-acetaminophen (5-325 mg) and a survey assessing pain and narcotic/nonnarcotic use on postoperative days 0 to 7.A total of 64 patients completed surveys. Mean ± SD narcotic use over the 7-day postoperative period was 7.7 ± 7.6 pills. Patients with high narcotic use (>6 pills total) had no differences in demographic or surgical factors from those with low use (≤6 pills) but did report a higher level of postoperative day 1 pain (4.8 ± 1.1 vs 2.0 ± 1.4, P < .001). Narcotic use declined during this period, with <30% of patients requiring narcotics by postoperative day 3.Our results support reduced opiate prescription and encouragement of nonnarcotic use after ESS without compromising effective pain management.
科研通智能强力驱动
Strongly Powered by AbleSci AI